INSIGHTS ON QUALITY ASSURANCE
-
Developing A Project Management Office (PMO) At A Small Manufacturing Site
Discover how implementing a Project Management Office transformed a small manufacturing site into a high-performing, strategic asset within a global network.
-
Leveraging Integrated Media Services For Speed And Efficiency
Uncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.
-
Compliance Under Transformation: Life Sciences And AI At The Crossroads
Explore how FDA modernization and AI-driven processes are redefining compliance expectations, as well as what devices and teams can do now to align standards and strengthen quality systems.
-
Aggregate Analysis Of Tirzepatide
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Minimizing Particulate Risk5/13/2026
While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.
-
Cryogenic Storage Of IV Bags For Cell And Gene Therapies12/18/2025
Cryogenic storage can compromise packaging integrity for cell and gene therapies. Learn how vacuum decay technology detects micro leaks and ensures product safety under extreme conditions.
-
High-Throughput Pyrogen Testing In A Multimode Microplate Reader3/20/2026
Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.
-
Conducting A CDMO Audit Day Efficiently: Practical Strategies12/30/2025
Efficient CDMO audits require strategic planning, clear communication, and real-time documentation to manage risks, avoid pitfalls, and strengthen compliance while protecting profitability and fostering collaborative partnerships.
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations8/27/2025
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
QUALITY ASSURANCE SOLUTIONS
-
Finding a strategic CDMO partner that will offer tailored solutions for your late phase clinical and commercial needs, mitigate risks, and bolster your supply chain is crucial for meeting project milestones on time.
-
Ensure Compliance. Safeguard Sterility. Drive Manufacturing Excellence.
-
The CC-IS is a Cell Culture Isolator cGMP Class A/ISO 5 system specifically designed to provide the users with a cell culture environment which is safer than environments on traditional biosafety cabinets, clean booths or standard cleanrooms, by eliminating any risk from human contamination of cell cultures.
-
Unlock higher yields and ensure regulatory success with a tailored process optimization program designed to eliminate contamination risks and stabilize biopharmaceutical workflows.
-
Discover a global CDMO that provides flexible small molecule development, manufacturing, and analytical services to accelerate drug commercialization and improve efficiency.